Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The B-Raf family includes ARAF, BRAF, and CRAF (RAF1), which are serine/threonine kinases that play a central role in the RAS-RAF-MEK-ERK signaling pathway. This pathway regulates cell growth, differentiation, survival, and development. Dysregulation, particularly mutations in BRAF, is a major contributor to human cancer. Germline mutations in BRAF or CRAF can cause developmental syndromes known as "RASopathies".
Inhibition of BRAF kinase activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B-Raf family (RAF).